The Janus Face of Coronavirus Disease 2019-Associated Coagulopathy
- PMID: 34048369
- PMCID: PMC8439634
- DOI: 10.1097/CCM.0000000000005128
The Janus Face of Coronavirus Disease 2019-Associated Coagulopathy
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
The authors reply.Crit Care Med. 2021 Oct 1;49(10):e1050-e1051. doi: 10.1097/CCM.0000000000005199. Crit Care Med. 2021. PMID: 34166291 Free PMC article. No abstract available.
Comment on
-
A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation.Crit Care Med. 2021 Jul 1;49(7):e663-e672. doi: 10.1097/CCM.0000000000004971. Crit Care Med. 2021. PMID: 33861545
References
-
- Doyle AJ, Hunt BJ, Sanderson B, et al. : A comparison of thrombosis and hemorrhage rates in patients with severe respiratory failure due to coronavirus disease 2019 and influenza requiring extracorporeal membrane oxygenation. Crit Care Med. 2021; 49:e663–e672 - PubMed
-
- Combes A, Hajage D, Capellier G, et al. ; EOLIA Trial Group, REVA, and ECMONet: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018; 378:1965–1975 - PubMed
-
- Pham T, Combes A, Rozé H, et al. ; REVA Research Network: Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2013; 187:276–285 - PubMed
-
- Vignoli A, Marchetti M, Balducci D, et al. : Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties. Haematologica. 2006; 91:207–214 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical